{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:48:09Z","timestamp":1790369289875,"version":"4.1.0"},"reference-count":235,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T00:00:00Z","timestamp":1563926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Human cytomegalovirus (HCMV) is ubiquitously prevalent. HCMV infection is typically asymptomatic and controlled by the immune system in healthy individuals, yet HCMV can be severely pathogenic for the fetus during pregnancy and in immunocompromised persons, such as transplant recipients or HIV infected patients. HCMV has co-evolved with the hosts, developed strategies to hide from immune effector cells and to successfully survive in the human organism. One strategy for evading or delaying the immune response is maintenance of the viral genome to establish the phase of latency. Furthermore, HCMV immune evasion involves the downregulation of human leukocyte antigens (HLA)-Ia molecules to hide infected cells from T-cell recognition. HCMV expresses several proteins that are described for downregulation of the HLA class I pathway via various mechanisms. Here, we review the wide range of immune evasion mechanisms of HCMV. Understanding the mechanisms of HCMV immune evasion will contribute to the development of new customized therapeutic strategies against the virus.<\/jats:p>","DOI":"10.3390\/ijms20153626","type":"journal-article","created":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T10:48:19Z","timestamp":1563965299000},"page":"3626","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Battle between Host Immune Cellular Responses and HCMV Immune Evasion"],"prefix":"10.3390","volume":"20","author":[{"given":"Trishna","family":"Manandhar","sequence":"first","affiliation":[{"name":"Institute for Transfusion Medicine, Hannover Medical School, 30625 Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gia-Gia T.","family":"H\u00f2","sequence":"additional","affiliation":[{"name":"Institute for Transfusion Medicine, Hannover Medical School, 30625 Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebke C.","family":"Pump","sequence":"additional","affiliation":[{"name":"Institute for Transfusion Medicine, Hannover Medical School, 30625 Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Blasczyk","sequence":"additional","affiliation":[{"name":"Institute for Transfusion Medicine, Hannover Medical School, 30625 Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5826-1989","authenticated-orcid":false,"given":"Christina","family":"Bade-Doeding","sequence":"additional","affiliation":[{"name":"Institute for Transfusion Medicine, Hannover Medical School, 30625 Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,7,24]]},"reference":[{"key":"ref_1","first-page":"945","article-title":"Uber protozoenartige zellen in der niere eines syphilitischen neugoborenen und in der parotis von kindern","volume":"15","author":"Ribbert","year":"1904","journal-title":"Zentralbl. Allg. Pathol."},{"key":"ref_2","first-page":"415","article-title":"Concerning the nature of \u201cproteozoan-like\u201d cells in certain lesions of infancy","volume":"21","author":"Goodpasture","year":"1921","journal-title":"Am. J. Dis. Child."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3181\/00379727-92-22498","article-title":"Propagation in tissue cultures of a cytopathogenic virus from human salivary gland virus (SGV) disease","volume":"92","author":"Smith","year":"1956","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3181\/00379727-92-22497","article-title":"Cytopathogenic agent resembling human salivary gland virus recovered from tissue cultures of human adenoids","volume":"92","author":"Rowe","year":"1956","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3181\/00379727-94-22841","article-title":"Isolation of intranuclear inclusion producing agents from infants with illnesses resembling cytomegalic inclusion disease","volume":"94","author":"Craig","year":"1957","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/path.4437","article-title":"The pathogenesis of human cytomegalovirus","volume":"235","author":"Griffiths","year":"2015","journal-title":"J. Pathol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1086\/508173","article-title":"Seroprevalence of cytomegalovirus infection in the United States, 1988\u20131994","volume":"43","author":"Staras","year":"2006","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.hoc.2010.11.011","article-title":"Cytomegalovirus in hematopoietic stem cell transplant recipients","volume":"25","author":"Ljungman","year":"2011","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0923-1811(99)00085-7","article-title":"Current understanding of cytomegalovirus infection in immunocompetent individuals","volume":"22","author":"Kano","year":"2000","journal-title":"J. Dermatol. Sci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1097\/QAD.0b013e32833016e8","article-title":"Acute cytomegalovirus infection in Kenyan HIV-infected infants","volume":"23","author":"Slyker","year":"2009","journal-title":"Aids"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcv.2006.03.005","article-title":"Cytomegalovirus disease in the era of highly active antiretroviral therapy (HAART)","volume":"37","author":"Steininger","year":"2006","journal-title":"J. Clin. Virol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1093\/clinids\/24.5.836","article-title":"Cytomegalovirus (CMV) viremia and the CD4+ lymphocyte count as predictors of CMV disease in patients infected with human immunodeficiency virus","volume":"24","author":"Gerard","year":"1997","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJM199203053261003","article-title":"The outcome of congenital cytomegalovirus infection in relation to maternal antibody status","volume":"326","author":"Fowler","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1093\/cid\/cit629","article-title":"Congenital Cytomegalovirus Infection: Clinical Outcome","volume":"57","author":"Boppana","year":"2013","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/cid\/cit018","article-title":"Long-term outcomes of congenital cytomegalovirus infection in Sweden and the United Kingdom","volume":"56","author":"Townsend","year":"2013","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/rmv.544","article-title":"New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection","volume":"17","author":"Dollard","year":"2007","journal-title":"Rev. Med. Virol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/cid\/ciw668","article-title":"Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials","volume":"64","author":"Ljungman","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.3389\/fmicb.2015.01016","article-title":"Ongoing burden of disease and mortality from HIV\/CMV coinfection in Africa in the antiretroviral therapy era","volume":"6","author":"Adland","year":"2015","journal-title":"Front. Microbiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1172\/JCI45449","article-title":"Cytomegalovirus: Pathogen, paradigm, and puzzle","volume":"121","author":"Boeckh","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e00445","DOI":"10.1016\/j.idcr.2018.e00445","article-title":"Cytomegalovirus acute infection with pulmonary involvement in an immunocompetent patient","volume":"14","author":"Goncalves","year":"2018","journal-title":"IDCases"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.idc.2009.10.008","article-title":"Cytomegalovirus pneumonia: Community-acquired pneumonia in immunocompetent hosts","volume":"24","author":"Cunha","year":"2010","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.bbmt.2010.03.020","article-title":"Evidence for a bidirectional relationship between cytomegalovirus replication and acute graft-versus-host disease","volume":"16","author":"Cantoni","year":"2010","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_23","first-page":"349","article-title":"Pathogenesis of GVHD: Role of herpes viruses","volume":"11","author":"Appleton","year":"1993","journal-title":"Bone Marrow Transplant."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/jcp.45.6.542","article-title":"Increase in severity of graft versus host disease by cytomegalovirus","volume":"45","author":"McCarthy","year":"1992","journal-title":"J. Clin. Pathol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1182\/blood-2003-10-3616","article-title":"The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy","volume":"103","author":"Boeckh","year":"2004","journal-title":"Blood"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/MOH.0000000000000085","article-title":"The role of cytomegalovirus serostatus on outcome of hematopoietic stem cell transplantation","volume":"21","author":"Ljungman","year":"2014","journal-title":"Curr. Opin. Hematol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1182\/blood-2002-10-3263","article-title":"Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: An EBMT megafile analysis","volume":"102","author":"Ljungman","year":"2003","journal-title":"Blood"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/35008096","article-title":"Rapid degradation of a large fraction of newly synthesized proteins by proteasomes","volume":"404","author":"Schubert","year":"2000","journal-title":"Nature"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0968-0004(02)02090-X","article-title":"Powering the peptide pump: TAP crosstalk with energetic nucleotides","volume":"27","author":"Saveanu","year":"2002","journal-title":"Trends Biochem. Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1600-065X.1999.tb01353.x","article-title":"The nature of the MHC class I peptide loading complex","volume":"172","author":"Cresswell","year":"1999","journal-title":"Immunol. Rev."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev.immunol.16.1.323","article-title":"Mechanisms of MHC class I restricted antigen processing","volume":"16","author":"Pamer","year":"1998","journal-title":"Annu. Rev. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0952-7915(02)00010-9","article-title":"Assembly and export of MHC class I peptide ligands","volume":"15","author":"Antoniou","year":"2003","journal-title":"Curr. Opin. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S1074-7613(00)00081-9","article-title":"Selective export of MHC class I molecules from the ER after their dissociation from TAP","volume":"13","author":"Spiliotis","year":"2000","journal-title":"Immunity"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1286-4579(03)00031-5","article-title":"TAP-independent antigen presentation on MHC class I molecules: Lessons from Epstein-Barr virus","volume":"5","author":"Lautscham","year":"2003","journal-title":"Microbes Infect."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0008-8749(02)00015-1","article-title":"Assembly and cell surface expression of TAP-independent, chloroquine-sensitive and interferon-gamma-inducible class I MHC complexes in transformed fibroblast cell lines are regulated by tapasin","volume":"215","author":"Fromm","year":"2002","journal-title":"Cell. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1073\/pnas.1222342110","article-title":"Tapasin-related protein TAPBPR is an additional component of the MHC class I presentation pathway","volume":"110","author":"Boyle","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"13585","DOI":"10.1073\/pnas.1735466100","article-title":"Reevaluation of human cytomegalovirus coding potential","volume":"100","author":"Murphy","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1099\/vir.0.015891-0","article-title":"Sequences of complete human cytomegalovirus genomes from infected cell cultures and clinical specimens","volume":"91","author":"Cunningham","year":"2010","journal-title":"J. Gen. Virol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/978-3-540-77349-8_4","article-title":"Cytomegalovirus Cell Tropism","volume":"Volume 325","author":"Shenk","year":"2008","journal-title":"Human Cytomegalovirus"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1128\/JVI.79.4.2160-2170.2005","article-title":"Complex Formation by Glycoproteins M and N of Human Cytomegalovirus: Structural and Functional Aspects","volume":"79","author":"Mach","year":"2005","journal-title":"J. Virol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"18153","DOI":"10.1073\/pnas.0509201102","article-title":"Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism","volume":"102","author":"Wang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/rmv.645","article-title":"Human cytomegalovirus tropism for endothelial\/epithelial cells: Scientific background and clinical implications","volume":"20","author":"Revello","year":"2010","journal-title":"Rev. Med. Virol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"8333","DOI":"10.1128\/JVI.78.15.8333-8341.2004","article-title":"Coiled-Coil Domains in Glycoproteins B and H Are Involved in Human Cytomegalovirus Membrane Fusion","volume":"78","author":"Lopper","year":"2004","journal-title":"J. Virol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Arvin, A.M., Mocarski, E.S., Moore, P., Whitley, R., Yamanishi, K., Campadelli-Fiume, G., and Roizman, B. (2007). Early events in human cytomegalovirus infection. Human Herpesviruses: Biology, Therapy and Immunoprophylaxis, Cambridge University Press. 25 February 2011.","DOI":"10.1017\/CBO9780511545313"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0042-6822(81)90249-X","article-title":"Human cytomegalovirus DNA: Restriction enzyme cleavage maps and map locations for immediate-early, early, and late RNAs","volume":"114","author":"Demarchi","year":"1981","journal-title":"Virology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1128\/jvi.41.2.462-477.1982","article-title":"Temporal patterns of human cytomegalovirus transcription: Mapping the viral RNAs synthesized at immediate early, early, and late times after infection","volume":"41","author":"Wathen","year":"1982","journal-title":"J. Virol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1128\/jvi.26.3.686-701.1978","article-title":"Sequence of protein synthesis in cells infected by human cytomegalovirus: Early and late virus-induced polypeptides","volume":"26","author":"Stinski","year":"1978","journal-title":"J. Virol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1128\/jvi.49.1.190-199.1984","article-title":"Structural analysis of the major immediate early gene of human cytomegalovirus","volume":"49","author":"Stenberg","year":"1984","journal-title":"J. Virol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1128\/jvi.56.3.665-675.1985","article-title":"Multiple spliced and unspliced transcripts from human cytomegalovirus immediate-early region 2 and evidence for a common initiation site within immediate-early region 1","volume":"56","author":"Stenberg","year":"1985","journal-title":"J. Virol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Arvin, A., Campadelli-Fiume, G., Mocarski, E., Moore, P.S., Roizman, B., Whitley, R., and Yamanishi, K. (2007). Early viral gene expression and function. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis, Cambridge University Press. 25 February 2011.","DOI":"10.1017\/CBO9780511545313"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1128\/jvi.64.4.1498-1506.1990","article-title":"Transactivation of a human cytomegalovirus early promoter by gene products from the immediate-early gene IE2 and augmentation by IE1: Mutational analysis of the viral proteins","volume":"64","author":"Malone","year":"1990","journal-title":"J. Virol."},{"key":"ref_52","first-page":"1238","article-title":"In vivo and in vitro analysis of transcriptional activation mediated by the human cytomegalovirus major immediate-early proteins","volume":"13","author":"Klucher","year":"1993","journal-title":"Mol. Cell. Biol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"5613","DOI":"10.1128\/jvi.68.9.5613-5622.1994","article-title":"Site-specific binding of the human cytomegalovirus IE2 86-kilodalton protein to an early gene promoter","volume":"68","author":"Schwartz","year":"1994","journal-title":"J. Virol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1128\/jvi.65.2.887-896.1991","article-title":"Human cytomegalovirus IE2 negatively regulates alpha gene expression via a short target sequence near the transcription start site","volume":"65","author":"Cherrington","year":"1991","journal-title":"J. Virol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"7612","DOI":"10.1128\/jvi.69.12.7612-7621.1995","article-title":"Binding of cellular repressor protein or the IE2 protein to a cis-acting negative regulatory element upstream of a human cytomegalovirus early promoter","volume":"69","author":"Huang","year":"1995","journal-title":"J. Virol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1128\/jvi.65.2.897-903.1991","article-title":"A cis-acting element in the major immediate-early (IE) promoter of human cytomegalovirus is required for negative regulation by IE2","volume":"65","author":"Liu","year":"1991","journal-title":"J. Virol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1128\/JVI.80.2.920-928.2006","article-title":"Human Cytomegalovirus Immediate-Early 2 Protein IE86 Blocks Virus-Induced Chemokine Expression","volume":"80","author":"Taylor","year":"2006","journal-title":"J. Virol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"6724","DOI":"10.1128\/jvi.65.12.6724-6734.1991","article-title":"Human cytomegalovirus UL36-38 and US3 immediate-early genes: Temporally regulated expression of nuclear, cytoplasmic, and polysome-associated transcripts during infection","volume":"65","author":"Tenney","year":"1991","journal-title":"J. Virol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"11327","DOI":"10.1073\/pnas.93.21.11327","article-title":"Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains","volume":"93","author":"Jones","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1128\/JVI.79.1.661-667.2005","article-title":"Natural killer cells utilize both perforin and gamma interferon to regulate murine cytomegalovirus infection in the spleen and liver","volume":"79","author":"Loh","year":"2005","journal-title":"J. Virol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1084\/jem.20150712","article-title":"Type I IFN promotes NK cell expansion during viral infection by protecting NK cells against fratricide","volume":"213","author":"Madera","year":"2016","journal-title":"J. Exp. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1084\/jem.161.1.40","article-title":"Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo","volume":"161","author":"Bukowski","year":"1985","journal-title":"J. Exp. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1128\/jvi.52.1.119-128.1984","article-title":"Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice","volume":"52","author":"Bukowski","year":"1984","journal-title":"J. Virol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJM198906293202605","article-title":"Severe Herpesvirus Infections in an Adolescent without Natural Killer Cells","volume":"320","author":"Biron","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"7568","DOI":"10.4049\/jimmunol.175.11.7568","article-title":"Human NK cells inhibit cytomegalovirus replication through a noncytolytic mechanism involving lymphotoxin-dependent induction of IFN-beta","volume":"175","author":"Iversen","year":"2005","journal-title":"J. Immunol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1128\/JVI.03489-14","article-title":"Natural Killer Cells Can Inhibit the Transmission of Human Cytomegalovirus in Cell Culture by Using Mechanisms from Innate and Adaptive Immune Responses","volume":"89","author":"Wu","year":"2015","journal-title":"J. Virol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.bbmt.2008.11.030","article-title":"The effect of single and combined activating KIR genotypes on CMV infection and immunity after hematopoietic cell transplantation","volume":"15","author":"Zaia","year":"2009","journal-title":"Biol. Blood Marrow Transplant. J. Am. Soc. Blood Marrow Transplant."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/sj.bmt.1705468","article-title":"Activating KIR genes are associated with CMV reactivation and survival after non-T-cell depleted HLA-identical sibling bone marrow transplantation for malignant disorders","volume":"38","author":"Chen","year":"2006","journal-title":"Bone Marrow Transplant."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1128\/JVI.77.8.4588-4596.2003","article-title":"Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2","volume":"77","author":"Compton","year":"2003","journal-title":"J. Virol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"7094","DOI":"10.4049\/jimmunol.177.10.7094","article-title":"Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells","volume":"177","author":"Boehme","year":"2006","journal-title":"J. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/01.tp.0000226071.12562.1a","article-title":"Impact of cytomegalovirus in organ transplant recipients in the era of antiviral prophylaxis","volume":"81","author":"Limaye","year":"2006","journal-title":"Transplantation"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1126\/science.1352912","article-title":"Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones","volume":"257","author":"Riddell","year":"1992","journal-title":"Science"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/bmt.2012.262","article-title":"Viral-specific adoptive immunotherapy after allo-SCT: The role of multimer-based selection strategies","volume":"48","author":"Ramirez","year":"2013","journal-title":"Bone Marrow Transplant."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1182\/blood-2010-01-262089","article-title":"Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation","volume":"116","author":"Feuchtinger","year":"2010","journal-title":"Blood"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1517\/14712598.2014.908847","article-title":"Therapeutic strategies for cytomegalovirus infection in haematopoietic transplant recipients: A focused update","volume":"14","author":"Sellar","year":"2014","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1742-4933-9-23","article-title":"CMV and Immunosenescence: From basics to clinics","volume":"9","author":"Solana","year":"2012","journal-title":"Immun. Ageing"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2217\/fvl.12.8","article-title":"The immune response to human CMV","volume":"7","author":"Diamond","year":"2012","journal-title":"Future Virol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.autrev.2017.11.018","article-title":"NK cells in autoimmune diseases: Linking innate and adaptive immune responses","volume":"17","author":"Gianchecchi","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Paust, S., Blish, C.A., and Reeves, R.K. (2017). Redefining Memory: Building the Case for Adaptive NK Cells. J. Virol., 91.","DOI":"10.1128\/JVI.00169-17"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.immuni.2019.04.009","article-title":"Cytomegalovirus Infection Drives Avidity Selection of Natural Killer Cells","volume":"50","author":"Adams","year":"2019","journal-title":"Immunity"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1099\/vir.0.83523-0","article-title":"Human cytomegalovirus serum neutralizing antibodies block virus infection of endothelial\/epithelial cells, but not fibroblasts, early during primary infection","volume":"89","author":"Gerna","year":"2008","journal-title":"J. Gen. Virol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1128\/JVI.01809-09","article-title":"Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH\/gL\/UL128-131A complex","volume":"84","author":"Macagno","year":"2010","journal-title":"J. Virol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1128\/CMR.15.4.680-715.2002","article-title":"Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn Infant","volume":"15","author":"Revello","year":"2002","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-2249.2008.03785.x","article-title":"Cytomegalovirus-seropositivity has a profound influence on the magnitude of major lymphoid subsets within healthy individuals","volume":"155","author":"Chidrawar","year":"2009","journal-title":"Clin. Exp. Immunol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.4049\/jimmunol.169.4.1984","article-title":"Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals","volume":"169","author":"Khan","year":"2002","journal-title":"J. Immunol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.0105-2896.2005.00271.x","article-title":"Human immunosenescence: Is it infectious?","volume":"205","author":"Pawelec","year":"2005","journal-title":"Immunol. Rev."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1002\/1521-4141(200006)30:6<1676::AID-IMMU1676>3.0.CO;2-V","article-title":"Analysis of CD8 T cell reactivity to cytomegalovirus using protein-spanning pools of overlapping pentadecapeptides","volume":"30","author":"Kern","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1128\/JVI.77.9.5226-5240.2003","article-title":"Ex Vivo Profiling of CD8+-T-Cell Responses to Human Cytomegalovirus Reveals Broad and Multispecific Reactivities in Healthy Virus Carriers","volume":"77","author":"Elkington","year":"2003","journal-title":"J. Virol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1084\/jem.20050882","article-title":"Broadly targeted human cytomegalovirus-specific CD4(+) and CD8(+) T cells dominate the memory compartments of exposed subjects","volume":"202","author":"Sylwester","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2007-01-070078","article-title":"Human cytomegalovirus sequences expressed in latently infected individuals promote a latent infection in vitro","volume":"110","author":"Goodrum","year":"2007","journal-title":"Blood"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1099\/vir.0.015602-0","article-title":"Analysis of latent viral gene expression in natural and experimental latency models of human cytomegalovirus and its correlation with histone modifications at a latent promoter","volume":"91","author":"Reeves","year":"2010","journal-title":"J. Gen. Virol."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Mason, G.M., Jackson, S., Okecha, G., Poole, E., Sissons, J.G.P., Sinclair, J., and Wills, M.R. (2013). Human cytomegalovirus latency-associated proteins elicit Immune-suppressive IL-10 producing CD4(+) T cells. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003635"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1099\/vir.0.020982-0","article-title":"CD8+ T-cell recognition of human cytomegalovirus latency-associated determinant pUL138","volume":"91","author":"Tey","year":"2010","journal-title":"J. Gen. Virol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1182\/blood.V99.11.3916","article-title":"Infusion of cytomegalovirus (CMV)\u2013specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy","volume":"99","author":"Einsele","year":"2002","journal-title":"Blood"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"11432","DOI":"10.1073\/pnas.0504851102","article-title":"Contribution of T cell receptor affinity to overall avidity for virus-specific CD8+ T cell responses","volume":"102","author":"Kedzierska","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"128ra42","DOI":"10.1126\/scitranslmed.3003647","article-title":"T-cell receptor \u03b1\u03b2 diversity inversely correlates with pathogen-specific antibody levels in human cytomegalovirus infection","volume":"4","author":"Wang","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.4049\/jimmunol.151.8.3971","article-title":"Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopes","volume":"151","author":"Gavin","year":"1993","journal-title":"J. Immunol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1128\/CDLI.8.3.628-631.2001","article-title":"Gamma Interferon Expression in CD8(+) T Cells Is a Marker for Circulating Cytotoxic T Lymphocytes That Recognize an HLA A2-Restricted Epitope of Human Cytomegalovirus Phosphoprotein pp65","volume":"8","author":"Ghanekar","year":"2001","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/nri932","article-title":"Antigens and immunoevasins: Opponents in cytomegalovirus immune surveillance","volume":"2","author":"Reddehase","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.4049\/jimmunol.172.5.3260","article-title":"Persistent and Selective Deficiency of CD4+ T Cell Immunity to Cytomegalovirus in Immunocompetent Young Children","volume":"172","author":"Tu","year":"2004","journal-title":"J. Immunol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1111\/j.1600-6143.2005.00871.x","article-title":"Differences in CMV-specific T-cell levels and long-term susceptibility to CMV infection after kidney, heart and lung transplantation","volume":"5","author":"Sester","year":"2005","journal-title":"Am. J. Transplant."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1002\/eji.201343690","article-title":"Adoptive transfer of cytomegalovirus-specific effector CD4+ T cells provides antiviral protection from murine CMV infection","volume":"43","author":"Jeitziner","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"9527","DOI":"10.1128\/JVI.79.15.9527-9539.2005","article-title":"CD4+ T-cell reconstitution reduces cytomegalovirus in the immunocompromised brain","volume":"79","author":"Reuter","year":"2005","journal-title":"J. Virol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3389\/fimmu.2019.00687","article-title":"Human Cytomegalovirus Antigen Presentation by HLA-DR+ NKG2C+ Adaptive NK Cells Specifically Activates Polyfunctional Effector Memory CD4+ T Lymphocytes","volume":"10","author":"Ataya","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM199510193331603","article-title":"Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor","volume":"333","author":"Walter","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/cyto.b.20420","article-title":"Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations","volume":"74","author":"Gratama","year":"2008","journal-title":"Cytom. Part B Clin. Cytom."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3389\/fimmu.2015.00598","article-title":"A Diverse Repertoire of CD4 T Cells Targets the Immediate-Early 1 Protein of Human Cytomegalovirus","volume":"6","author":"Ameres","year":"2015","journal-title":"Front. Immunol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T Cells and Immune Tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1146\/annurev-immunol-020711-075043","article-title":"Induced CD4+Foxp3+ regulatory T cells in immune tolerance","volume":"30","author":"Bilate","year":"2012","journal-title":"Annu. Rev. Immunol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1093\/infdis\/jit576","article-title":"A novel cytomegalovirus-induced regulatory-type T-cell subset increases in size during older life and links virus-specific immunity to vascular pathology","volume":"209","author":"Terrazzini","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1128\/JVI.78.5.2454-2459.2004","article-title":"Human CD4+ CD25+ Regulatory T Cells Control T-Cell Responses to Human Immunodeficiency Virus and Cytomegalovirus Antigens","volume":"78","author":"Aandahl","year":"2004","journal-title":"J. Virol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jcv.2007.11.014","article-title":"Human cytomegalovirus: Latency and reactivation in the myeloid lineage","volume":"41","author":"Sinclair","year":"2008","journal-title":"J. Clin. Virol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1099\/vir.0.81891-0","article-title":"Latency and reactivation of human cytomegalovirus","volume":"87","author":"Sinclair","year":"2006","journal-title":"J. Gen. Virol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.3389\/fimmu.2018.02214","article-title":"HCMV-Encoded NK Modulators: Lessons From in vitro and in vivo Genetic Variation","volume":"9","author":"Patel","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.3390\/v4112448","article-title":"Human Cytomegalovirus Encoded Homologs of Cytokines, Chemokines and their Receptors: Roles in Immunomodulation","volume":"4","author":"McSharry","year":"2012","journal-title":"Viruses"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri980","article-title":"Viral mimicry of cytokines, chemokines and their receptors","volume":"3","author":"Alcami","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000053970","article-title":"Molecular Mimicry by Cytomegaloviruses","volume":"42","author":"Vink","year":"1999","journal-title":"Intervirology"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/clinids\/14.4.933","article-title":"Herpesviruses-immune escape artists?","volume":"14","author":"Banks","year":"1992","journal-title":"Clin. Infect. Dis."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"9536","DOI":"10.1128\/JVI.02636-06","article-title":"Phase-Dependent Immune Evasion of Herpesviruses","volume":"81","author":"Fishbain","year":"2007","journal-title":"J. Virol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"14506","DOI":"10.1073\/pnas.97.26.14506","article-title":"UL82 virion protein activates expression of immediate early viral genes in human cytomegalovirus-infected cells","volume":"97","author":"Bresnahan","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"9512","DOI":"10.1128\/JVI.78.17.9512-9523.2004","article-title":"Human cytomegalovirus tegument proteins ppUL82 (pp71) and ppUL35 interact and cooperatively activate the major immediate-early enhancer","volume":"78","author":"Schierling","year":"2004","journal-title":"J. Virol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1128\/JVI.80.2.951-963.2006","article-title":"Human Cytomegalovirus Protein pp71 Disrupts Major Histocompatibility Complex Class I Cell Surface Expression","volume":"80","author":"Trgovcich","year":"2006","journal-title":"J. Virol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"5229","DOI":"10.1128\/JVI.03484-12","article-title":"Human Cytomegalovirus pp71 Stimulates Major Histocompatibility Complex Class I Presentation of IE1-Derived Peptides at Immediate Early Times of Infection","volume":"87","author":"Hesse","year":"2013","journal-title":"J. Virol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"10995","DOI":"10.1128\/JVI.78.20.10995-11006.2004","article-title":"Major human cytomegalovirus structural protein pp65 (ppUL83) prevents interferon response factor 3 activation in the interferon response","volume":"78","author":"Abate","year":"2004","journal-title":"J. Virol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"11439","DOI":"10.1073\/pnas.1534570100","article-title":"Human cytomegalovirus UL83-coded pp65 virion protein inhibits antiviral gene expression in infected cells","volume":"100","author":"Browne","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1086\/322039","article-title":"Expression dynamics of human cytomegalovirus immune evasion genes US3, US6, and US11 in the blood of lung transplant recipients","volume":"184","author":"Greijer","year":"2001","journal-title":"J. Infect. Dis."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1097\/01.tp.0000261105.34233.4f","article-title":"A prospective assessment of cytomegalovirus immune evasion gene transcription profiles in transplant patients with cytomegalovirus infection","volume":"83","author":"Humar","year":"2007","journal-title":"Transplantation"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"4830","DOI":"10.1128\/jvi.69.8.4830-4841.1995","article-title":"Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains","volume":"69","author":"Jones","year":"1995","journal-title":"J. Virol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"10990","DOI":"10.1073\/pnas.93.20.10990","article-title":"Human cytomegalovirus inhibits antigen presentation by a sequential multistep process","volume":"93","author":"Ahn","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1034\/j.1600-0854.2000.010405.x","article-title":"Human cytomegalovirus immediate early glycoprotein US3 retains MHC class I molecules by transient association","volume":"1","author":"Gruhler","year":"2000","journal-title":"Traffic"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S1074-7613(03)00355-8","article-title":"Human cytomegalovirus inhibits tapasin-dependent peptide loading and optimization of the MHC class I peptide cargo for immune evasion","volume":"20","author":"Park","year":"2004","journal-title":"Immunity"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.cell.2006.08.041","article-title":"Redox regulation facilitates optimal peptide selection by MHC class I during antigen processing","volume":"127","author":"Park","year":"2006","journal-title":"Cell"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.molimm.2012.03.024","article-title":"Human cytomegalovirus US3 modulates destruction of MHC class I molecules","volume":"51","author":"Noriega","year":"2012","journal-title":"Mol. Immunol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0022-2836(86)90359-1","article-title":"Sequence of the short unique region, short repeats, and part of the long repeats of human cytomegalovirus","volume":"192","author":"Weston","year":"1986","journal-title":"J. Mol. Biol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1093\/nar\/21.12.2931","article-title":"The human cytomegalovirus US3 immediate-early protein lacking the putative transmembrane domain regulates gene expression","volume":"21","author":"Tenney","year":"1993","journal-title":"Nucleic Acids Res."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"11262","DOI":"10.1128\/JVI.74.23.11262-11269.2000","article-title":"Structural and functional dissection of human cytomegalovirus US3 in binding major histocompatibility complex class I molecules","volume":"74","author":"Lee","year":"2000","journal-title":"J. Virol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1128\/JVI.77.3.2147-2156.2003","article-title":"Determinant for endoplasmic reticulum retention in the luminal domain of the human cytomegalovirus US3 glycoprotein","volume":"77","author":"Lee","year":"2003","journal-title":"J. Virol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1128\/JVI.78.1.413-423.2004","article-title":"Structural and functional analysis of human cytomegalovirus US3 protein","volume":"78","author":"Misaghi","year":"2004","journal-title":"J. Virol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.biocel.2008.10.012","article-title":"Human cytomegalovirus: Host immune modulation by the viral US3 gene","volume":"41","author":"Liu","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1006\/viro.2002.1557","article-title":"Analysis of human cytomegalovirus US3 gene products","volume":"301","author":"Liu","year":"2002","journal-title":"Virology"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1128\/JVI.02397-05","article-title":"A short isoform of human cytomegalovirus US3 functions as a dominant negative inhibitor of the full-length form","volume":"80","author":"Shin","year":"2006","journal-title":"J. Virol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1128\/jvi.71.4.2970-2979.1997","article-title":"Human cytomegalovirus US2 destabilizes major histocompatibility complex class I heavy chains","volume":"71","author":"Jones","year":"1997","journal-title":"J. Virol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/384432a0","article-title":"Sec6l-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction","volume":"384","author":"Wiertz","year":"1996","journal-title":"Nature"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"8265","DOI":"10.1128\/JVI.76.16.8265-8275.2002","article-title":"Binding of Human Cytomegalovirus US2 to Major Histocompatibility Complex Class I and II Proteins Is Not Sufficient for Their Degradation","volume":"76","author":"Chevalier","year":"2002","journal-title":"J. Virol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"6794","DOI":"10.1073\/pnas.121172898","article-title":"Antigen presentation subverted: Structure of the human cytomegalovirus protein US2 bound to the class I molecule HLA-A2","volume":"98","author":"Gewurz","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/cmi.2014.105","article-title":"Classical and non-classical MHC I molecule manipulation by human cytomegalovirus: So many targets[mdash]but how many arrows in the quiver?","volume":"12","author":"Halenius","year":"2015","journal-title":"Cell. Mol. Immunol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.1128\/JVI.75.11.5197-5204.2001","article-title":"Human cytomegalovirus US2 endoplasmic reticulum-lumenal domain dictates association with major histocompatibility complex class I in a locus-specific manner","volume":"75","author":"Gewurz","year":"2001","journal-title":"J. Virol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"6757","DOI":"10.4049\/jimmunol.171.12.6757","article-title":"Human cytomegalovirus-encoded US2 differentially affects surface expression of MHC class I locus products and targets membrane-bound, but not soluble HLA-G1 for degradation","volume":"171","author":"Barel","year":"2003","journal-title":"J. Immunol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1083\/jcb.200906110","article-title":"The TRC8 E3 ligase ubiquitinates MHC class I molecules before dislocation from the ER","volume":"186","author":"Stagg","year":"2009","journal-title":"J. Cell Biol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.molimm.2015.07.005","article-title":"Identifying the ERAD ubiquitin E3 ligases for viral and cellular targeting of MHC class I","volume":"68","author":"Lehner","year":"2015","journal-title":"Mol. Immunol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1242\/jcs.206839","article-title":"Multiple E2 ubiquitin-conjugating enzymes regulate human cytomegalovirus US2-mediated immunoreceptor downregulation","volume":"130","author":"Schuren","year":"2017","journal-title":"J. Cell Sci."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/emboj\/20.7.1573","article-title":"Signal peptide cleavage of a type I membrane protein, HCMV US11, is dependent on its membrane anchor","volume":"20","author":"Rehm","year":"2001","journal-title":"EMBO J."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"11306","DOI":"10.1074\/jbc.M107904200","article-title":"US2, a Human Cytomegalovirus-encoded Type I Membrane Protein, Contains a Non-cleavable Amino-terminal Signal Peptide","volume":"277","author":"Gewurz","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nature04830","article-title":"Signal peptide peptidase is required for dislocation from the endoplasmic reticulum","volume":"441","author":"Loureiro","year":"2006","journal-title":"Nature"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1083\/jcb.201312009","article-title":"Cleavage by signal peptide peptidase is required for the degradation of selected tail-anchored proteins","volume":"205","author":"Boname","year":"2014","journal-title":"J. Cell Biol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/emboj.2009.359","article-title":"Protein disulphide isomerase is required for signal peptide peptidase-mediated protein degradation","volume":"29","author":"Lee","year":"2010","journal-title":"EMBO J."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1074\/jbc.M109765200","article-title":"Membrane-specific, Host-derived Factors Are Required for US2- and US11-mediated Degradation of Major Histocompatibility Complex Class I Molecules","volume":"277","author":"Furman","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Hsu, J.L., van den Boomen, D.J.H., Tomasec, P., Weekes, M.P., Antrobus, R., Stanton, R.J., Ruckova, E., Sugrue, D., Wilkie, G.S., and Davison, A.J. (2015). Plasma Membrane Profiling Defines an Expanded Class of Cell Surface Proteins Selectively Targeted for Degradation by HCMV US2 in Cooperation with UL141. PLoS Pathog., 11.","DOI":"10.1371\/journal.ppat.1004811"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"32352","DOI":"10.1074\/jbc.M110.131649","article-title":"The p97 ATPase Dislocates MHC Class I Heavy Chain in US2-expressing Cells via a Ufd1-Npl4-independent Mechanism","volume":"285","author":"Soetandyo","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1083\/jcb.200302169","article-title":"Function of the p97-Ufd1-Npl4 complex in retrotranslocation from the ER to the cytosol: Dual recognition of nonubiquitinated polypeptide segments and polyubiquitin chains","volume":"162","author":"Ye","year":"2003","journal-title":"J. Cell Biol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cell.2004.11.013","article-title":"A series of ubiquitin binding factors connects CDC48\/p97 to substrate multiubiquitylation and proteasomal targeting","volume":"120","author":"Richly","year":"2005","journal-title":"Cell"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1083\/jcb.200605100","article-title":"Regulation of retrotranslocation by p97-associated deubiquitinating enzyme ataxin-3","volume":"174","author":"Wang","year":"2006","journal-title":"J. Cell Biol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0092-8674(00)81054-5","article-title":"The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol","volume":"84","author":"Wiertz","year":"1996","journal-title":"Cell"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-3-642-59421-2_3","article-title":"The HCMV Gene Products US2 and US11 Target MHC Class I Molecules for Degradation in the Cytosol","volume":"Volume 269","author":"Koszinowski","year":"2002","journal-title":"Viral Proteins Counteracting Host Defenses"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1128\/jvi.65.4.2024-2036.1991","article-title":"Fine mapping of transcripts expressed from the US6 gene family of human cytomegalovirus strain AD169","volume":"65","author":"Jones","year":"1991","journal-title":"J. Virol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.molimm.2005.07.005","article-title":"Human cytomegalovirus-encoded US2 and US11 target unassembled MHC class I heavy chains for degradation","volume":"43","author":"Barel","year":"2006","journal-title":"Mol. Immunol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1002\/eji.200323912","article-title":"Amino acid composition of alpha1\/alpha2 domains and cytoplasmic tail of MHC class I molecules determine their susceptibility to human cytomegalovirus US11-mediated down-regulation","volume":"33","author":"Barel","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.bbrc.2005.03.112","article-title":"Functional dissection of HCMV US11 in mediating the degradation of MHC class I molecules","volume":"330","author":"Lee","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1091\/mbc.e03-03-0192","article-title":"Dislocation of a Type I Membrane Protein Requires Interactions between Membrane-spanning Segments within the Lipid Bilayer","volume":"14","author":"Lilley","year":"2003","journal-title":"Mol. Biol. Cell."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"11425","DOI":"10.1073\/pnas.1409099111","article-title":"TMEM129 is a Derlin-1 associated ERAD E3 ligase essential for virus-induced degradation of MHC-I","volume":"111","author":"Timms","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature02592","article-title":"A membrane protein required for dislocation of misfolded proteins from the ER","volume":"429","author":"Lilley","year":"2004","journal-title":"Nature"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/nature02656","article-title":"A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol","volume":"429","author":"Ye","year":"2004","journal-title":"Nature"},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Cho, S., Kim, B.Y., Ahn, K., and Jun, Y. (2013). The C-Terminal Amino Acid of the MHC-I Heavy Chain Is Critical for Binding to Derlin-1 in Human Cytomegalovirus US11-Induced MHC-I Degradation. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0072356"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1038\/ncomms4832","article-title":"A high-coverage shRNA screen identifies TMEM129 as an E3 ligase involved in ER-associated protein degradation","volume":"5","author":"Bassik","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"11589","DOI":"10.1073\/pnas.0605215103","article-title":"E2-25K mediates US11-triggered retro-translocation of MHC class I heavy chains in a permeabilized cell system","volume":"103","author":"Flierman","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1083\/jcb.200605196","article-title":"SEL1L, the homologue of yeast Hrd3p, is involved in protein dislocation from the mammalian ER","volume":"175","author":"Mueller","year":"2006","journal-title":"J. Cell Biol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1091\/mbc.12.8.2546","article-title":"Polyubiquitination Is Required for US11-dependent Movement of MHC Class I Heavy Chain from Endoplasmic Reticulum into Cytosol","volume":"12","author":"Shamu","year":"2001","journal-title":"Mol. Biol. Cell"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1042\/bj3580369","article-title":"Ubiquitination is essential for human cytomegalovirus US11-mediated dislocation of MHC class I molecules from the endoplasmic reticulum to the cytosol","volume":"358","author":"Kikkert","year":"2001","journal-title":"Biochem. J."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1083\/jcb.147.1.45","article-title":"The Pathway of Us11-Dependent Degradation of Mhc Class I Heavy Chains Involves a Ubiquitin-Conjugated Intermediate","volume":"147","author":"Shamu","year":"1999","journal-title":"J. Cell Biol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"30063","DOI":"10.1074\/jbc.M602248200","article-title":"Ubiquitination of MHC Class I Heavy Chains Is Essential for Dislocation by Human Cytomegalovirus-encoded US2 but Not US11","volume":"281","author":"Hassink","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.1073\/pnas.94.13.6904","article-title":"The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation","volume":"94","author":"Lehner","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S1074-7613(00)80350-7","article-title":"A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter","volume":"6","author":"Hengel","year":"1997","journal-title":"Immunity"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1515\/BC.2009.069","article-title":"The peptide-loading complex\u2014Antigen translocation and MHC class I loading","volume":"390","year":"2009","journal-title":"Biol. Chem."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1006\/jmbi.1999.3329","article-title":"Kinetic analysis of peptide binding to the TAP transport complex: Evidence for structural rearrangements induced by substrate binding","volume":"294","author":"Neumann","year":"1999","journal-title":"J. Mol. Biol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/emboj\/20.3.387","article-title":"The human cytomegalovirus gene product US6 inhibits ATP binding by TAP","volume":"20","author":"Hewitt","year":"2001","journal-title":"EMBO J."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1002\/j.1460-2075.1996.tb00689.x","article-title":"Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47","volume":"15","author":"Ahn","year":"1996","journal-title":"EMBO J."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"48031","DOI":"10.1074\/jbc.M108528200","article-title":"Molecular Mechanism and Structural Aspects of Transporter Associated with Antigen Processing Inhibition by the Cytomegalovirus Protein US6","volume":"276","author":"Kyritsis","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S1074-7613(00)80349-0","article-title":"The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP","volume":"6","author":"Ahn","year":"1997","journal-title":"Immunity"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1074\/jbc.M510223200","article-title":"Physical and functional interactions of the cytomegalovirus US6 glycoprotein with the transporter associated with antigen processing","volume":"281","author":"Halenius","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1128\/JVI.01705-07","article-title":"Structural and Functional Dissection of the Human Cytomegalovirus Immune Evasion Protein US6","volume":"82","author":"Dugan","year":"2008","journal-title":"J. Virol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"11753","DOI":"10.1128\/JVI.76.22.11753-11756.2002","article-title":"The human cytomegalovirus US10 gene product delays trafficking of major histocompatibility complex class I molecules","volume":"76","author":"Furman","year":"2002","journal-title":"J. Virol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1084\/jem.20091793","article-title":"The HCMV membrane glycoprotein US10 selectively targets HLA-G for degradation","volume":"207","author":"Park","year":"2010","journal-title":"J. Exp. Med."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"10557","DOI":"10.1128\/JVI.75.21.10557-10562.2001","article-title":"Human Cytomegalovirus Protein US2 Interferes with the Expression of Human HFE, a Nonclassical Class I Major Histocompatibility Complex Molecule That Regulates Iron Homeostasis","volume":"75","author":"Zimerman","year":"2001","journal-title":"J. Virol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1182\/blood-2002-07-2158","article-title":"A single viral protein HCMV US2 affects antigen presentation and intracellular iron homeostasis by degradation of classical HLA class I and HFE molecules","volume":"101","author":"Arieh","year":"2003","journal-title":"Blood"},{"key":"ref_195","doi-asserted-by":"crossref","unstructured":"Fielding, C.A., Aicheler, R., Stanton, R.J., Wang, E.C.Y., Han, S., Seirafian, S., Davies, J., McSharry, B.P., Weekes, M.P., and Antrobus, P.R. (2014). Two Novel Human Cytomegalovirus NK Cell Evasion Functions Target MICA for Lysosomal Degradation. PLoS Pathog., 10.","DOI":"10.1371\/journal.ppat.1004058"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jcv.2007.10.027","article-title":"Modulation of natural killer cells by human cytomegalovirus","volume":"41","author":"Wilkinson","year":"2008","journal-title":"J. Clin. Virol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/1521-4141(200105)31:5<1428::AID-IMMU1428>3.0.CO;2-4","article-title":"ULBP1, 2, 3: Novel MHC class I-related molecules that bind to human cytomegalovirus glycoprotein UL16, activate NK cells","volume":"31","author":"Kubin","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/immu.200390022","article-title":"Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein","volume":"33","author":"Welte","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1126\/science.1140956","article-title":"Host immune system gene targeting by a viral miRNA","volume":"317","author":"Elefant","year":"2007","journal-title":"Science"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/ni1190","article-title":"Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus","volume":"6","author":"Arnon","year":"2005","journal-title":"Nat. Immunol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.4049\/jimmunol.164.10.5019","article-title":"Cutting edge: The human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis","volume":"164","author":"Ulbrecht","year":"2000","journal-title":"J. Immunol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"7570","DOI":"10.1073\/pnas.112680099","article-title":"UL40-mediated NK evasion during productive infection with human cytomegalovirus","volume":"99","author":"Wang","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"4951","DOI":"10.4049\/jimmunol.160.10.4951","article-title":"HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences","volume":"160","author":"Lee","year":"1998","journal-title":"J. Immunol."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1126\/science.287.5455.1031","article-title":"Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40","volume":"287","author":"Tomasec","year":"2000","journal-title":"Science"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.4049\/jimmunol.178.7.4473","article-title":"The human cytomegalovirus MHC class I homolog UL18 inhibits LIR-1+ but activates LIR-1- NK cells","volume":"178","author":"Griffin","year":"2007","journal-title":"J. Immunol."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/386514a0","article-title":"The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells","volume":"386","author":"Reyburn","year":"1997","journal-title":"Nature"},{"key":"ref_207","doi-asserted-by":"crossref","unstructured":"Kim, Y., Park, B., Cho, S., Shin, J., Cho, K., Jun, Y., and Ahn, K. (2008). Human cytomegalovirus UL18 utilizes US6 for evading the NK and T-cell responses. PLoS Pathog., 4.","DOI":"10.1371\/journal.ppat.1000123"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"4775","DOI":"10.4049\/jimmunol.164.9.4775","article-title":"Human cytomegalovirus strain-dependent changes in NK cell recognition of infected fibroblasts","volume":"164","author":"Cerboni","year":"2000","journal-title":"J. Immunol."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ni1156","article-title":"Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141","volume":"6","author":"Tomasec","year":"2005","journal-title":"Nat. Immunol."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bbrc.2006.05.092","article-title":"Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142","volume":"346","author":"Chalupny","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_211","doi-asserted-by":"crossref","unstructured":"Dassa, L., Seidel, E., Oiknine-Djian, E., Yamin, R., Wolf, D.G., Le-Trilling, V.T.K., and Mandelboim, O. (2018). The Human Cytomegalovirus Protein UL148A Downregulates the NK Cell-Activating Ligand MICA To Avoid NK Cell Attack. J. Virol., 92.","DOI":"10.1128\/JVI.00162-18"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.chom.2014.07.005","article-title":"HCMV pUL135 remodels the actin cytoskeleton to impair immune recognition of infected cells","volume":"16","author":"Stanton","year":"2014","journal-title":"Cell Host Microbe"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1073\/pnas.1720950115","article-title":"Suppression of costimulation by human cytomegalovirus promotes evasion of cellular immune defenses","volume":"115","author":"Wang","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1055\/s-2006-945530","article-title":"Major complications following hematopoietic stem cell transplantation","volume":"27","author":"Afessa","year":"2006","journal-title":"Semin Respir. Crit. Care Med."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2174\/187152611797636640","article-title":"Antiviral Treatment of Cytomegalovirus Infection","volume":"11","author":"Amina","year":"2011","journal-title":"Infect. Disord. Drug Targets"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.antiviral.2006.05.002","article-title":"Antiviral drugs for cytomegalovirus diseases","volume":"71","author":"Biron","year":"2006","journal-title":"Antivir. Res."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1309533","article-title":"Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation","volume":"370","author":"Chemaly","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation","volume":"377","author":"Marty","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(03)14634-X","article-title":"Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines","volume":"362","author":"Peggs","year":"2003","journal-title":"Lancet"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1182\/blood-2016-01-628982","article-title":"T cells for viral infections after allogeneic hematopoietic stem cell transplant","volume":"127","author":"Bollard","year":"2016","journal-title":"Blood"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.bbmt.2015.05.015","article-title":"Immunotherapy with donor T cells sensitized with overlapping pentadecapeptides for treatment of persistent cytomegalovirus infection or viremia","volume":"21","author":"Koehne","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/cid\/ciq042","article-title":"Directly Selected Cytomegalovirus-Reactive Donor T Cells Confer Rapid and Safe Systemic Reconstitution of Virus-Specific Immunity Following Stem Cell Transplantation","volume":"52","author":"Peggs","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.bbmt.2007.02.004","article-title":"Ex Vivo Expansion and Prophylactic Infusion of CMV-pp65 Peptide-Specific Cytotoxic T-Lymphocytes following Allogeneic Hematopoietic Stem Cell Transplantation","volume":"13","author":"Micklethwaite","year":"2007","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.3389\/fimmu.2017.01591","article-title":"Comprehensive Analysis of Cytomegalovirus pp65 Antigen-Specific CD8(+) T Cell Responses According to Human Leukocyte Antigen Class I Allotypes and Intraindividual Dominance","volume":"8","author":"Hyun","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1038\/mt.2012.130","article-title":"Rapidly Generated Multivirus-specific Cytotoxic T Lymphocytes for the Prophylaxis and Treatment of Viral Infections","volume":"20","author":"Gerdemann","year":"2012","journal-title":"Mol. Ther."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1182\/blood-2003-05-1433","article-title":"Generation of CMV-specific T lymphocytes using protein-spanning pools of pp65-derived overlapping pentadecapeptides for adoptive immunotherapy","volume":"105","author":"Trivedi","year":"2005","journal-title":"Blood"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"242ra83","DOI":"10.1126\/scitranslmed.3008825","article-title":"Activity of Broad-Spectrum T Cells as Treatment for AdV, EBV, CMV, BKV, and HHV6 Infections after HSCT","volume":"6","author":"Papadopoulou","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/tan.13537","article-title":"Releasing the concept of HLA-allele specific peptide anchors in viral infections: A non-canonical naturally presented human cytomegalovirus-derived HLA-A*24:02 restricted peptide drives exquisite immunogenicity","volume":"94","author":"Pump","year":"2019","journal-title":"Hla"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1586\/erv.10.125","article-title":"Update on the current status of cytomegalovirus vaccines","volume":"9","author":"Sung","year":"2010","journal-title":"Expert Rev. Vaccines"},{"key":"ref_230","doi-asserted-by":"crossref","unstructured":"Schleiss, M.R. (2016). Current Status of Cytomegalovirus Vaccines, John Wiley & Sons Ltd.. Available online: http:\/\/www.els.net.","DOI":"10.1002\/9780470015902.a0024788"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.vaccine.2015.11.056","article-title":"Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial","volume":"34","author":"Bernstein","year":"2016","journal-title":"Vaccine"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0140-6736(11)60136-0","article-title":"Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: A phase 2 randomised placebo-controlled trial","volume":"377","author":"Griffiths","year":"2011","journal-title":"Lancet"},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.humimm.2004.02.005","article-title":"Progress made towards the development of a CMV peptide vaccine","volume":"65","author":"Paston","year":"2004","journal-title":"Hum. Immunol."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/039463201302600102","article-title":"Is HCMV vaccine an unmet need? The state of art of vaccine development","volume":"26","author":"Chiurchiu","year":"2013","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1080\/21645515.2016.1164376","article-title":"Preclinical evaluations of peptide-conjugate vaccines targeting the antigenic domain-2 of glycoprotein B of human cytomegalovirus","volume":"12","author":"Finnefrock","year":"2016","journal-title":"Hum. Vaccines Immunother."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/15\/3626\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:09:14Z","timestamp":1760188154000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/15\/3626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,24]]},"references-count":235,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2019,8]]}},"alternative-id":["ijms20153626"],"URL":"https:\/\/doi.org\/10.3390\/ijms20153626","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,24]]}}}